Cargando…
1,3‐Bis(aryloxy)propan‐2‐ols as potential antileishmanial agents
We describe herein the synthesis and antileishmanial activity of 1,3‐bis(aryloxy)propan‐2‐ols. Five compounds (2, 3, 13, 17, and 18) exhibited an effective antileishmanial activity against stationary promastigote forms of Leishmania amazonensis (IC (50) < 15.0 μm), and an influence of compound li...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5697679/ https://www.ncbi.nlm.nih.gov/pubmed/28590516 http://dx.doi.org/10.1111/cbdd.13024 |
_version_ | 1783280664863309824 |
---|---|
author | Lavorato, Stefânia N. Duarte, Mariana C. Lage, Daniela P. Tavares, Carlos A. P. Coelho, Eduardo A. F. Alves, Ricardo J. |
author_facet | Lavorato, Stefânia N. Duarte, Mariana C. Lage, Daniela P. Tavares, Carlos A. P. Coelho, Eduardo A. F. Alves, Ricardo J. |
author_sort | Lavorato, Stefânia N. |
collection | PubMed |
description | We describe herein the synthesis and antileishmanial activity of 1,3‐bis(aryloxy)propan‐2‐ols. Five compounds (2, 3, 13, 17, and 18) exhibited an effective antileishmanial activity against stationary promastigote forms of Leishmania amazonensis (IC (50) < 15.0 μm), and an influence of compound lipophilicity on activity was suggested. Most of the compounds were poorly selective, as they showed toxicity toward murine macrophages, except 17 and 18, which presented good selective indexes (SI ≥ 10.0). The five more active compounds (2, 3, 13, 17, and 18) were selected for the treatment of infected macrophages, and all of them were able to reduce the number of internalized parasites by more than 80%, as well as the number of infected macrophages by more than 70% in at least one of the tested concentrations. Altogether, these results demonstrate the potential of these compounds as new hits of antileishmanial agents and open future possibilities for them to be tested in in vivo studies. |
format | Online Article Text |
id | pubmed-5697679 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-56976792017-11-28 1,3‐Bis(aryloxy)propan‐2‐ols as potential antileishmanial agents Lavorato, Stefânia N. Duarte, Mariana C. Lage, Daniela P. Tavares, Carlos A. P. Coelho, Eduardo A. F. Alves, Ricardo J. Chem Biol Drug Des Research Articles We describe herein the synthesis and antileishmanial activity of 1,3‐bis(aryloxy)propan‐2‐ols. Five compounds (2, 3, 13, 17, and 18) exhibited an effective antileishmanial activity against stationary promastigote forms of Leishmania amazonensis (IC (50) < 15.0 μm), and an influence of compound lipophilicity on activity was suggested. Most of the compounds were poorly selective, as they showed toxicity toward murine macrophages, except 17 and 18, which presented good selective indexes (SI ≥ 10.0). The five more active compounds (2, 3, 13, 17, and 18) were selected for the treatment of infected macrophages, and all of them were able to reduce the number of internalized parasites by more than 80%, as well as the number of infected macrophages by more than 70% in at least one of the tested concentrations. Altogether, these results demonstrate the potential of these compounds as new hits of antileishmanial agents and open future possibilities for them to be tested in in vivo studies. John Wiley and Sons Inc. 2017-06-28 2017-11 /pmc/articles/PMC5697679/ /pubmed/28590516 http://dx.doi.org/10.1111/cbdd.13024 Text en © 2017 The Authors. Chemical Biology & Drug Design Published by John Wiley & Sons Ltd This is an open access article under the terms of the Creative Commons Attribution (http://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Articles Lavorato, Stefânia N. Duarte, Mariana C. Lage, Daniela P. Tavares, Carlos A. P. Coelho, Eduardo A. F. Alves, Ricardo J. 1,3‐Bis(aryloxy)propan‐2‐ols as potential antileishmanial agents |
title | 1,3‐Bis(aryloxy)propan‐2‐ols as potential antileishmanial agents |
title_full | 1,3‐Bis(aryloxy)propan‐2‐ols as potential antileishmanial agents |
title_fullStr | 1,3‐Bis(aryloxy)propan‐2‐ols as potential antileishmanial agents |
title_full_unstemmed | 1,3‐Bis(aryloxy)propan‐2‐ols as potential antileishmanial agents |
title_short | 1,3‐Bis(aryloxy)propan‐2‐ols as potential antileishmanial agents |
title_sort | 1,3‐bis(aryloxy)propan‐2‐ols as potential antileishmanial agents |
topic | Research Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5697679/ https://www.ncbi.nlm.nih.gov/pubmed/28590516 http://dx.doi.org/10.1111/cbdd.13024 |
work_keys_str_mv | AT lavoratostefanian 13bisaryloxypropan2olsaspotentialantileishmanialagents AT duartemarianac 13bisaryloxypropan2olsaspotentialantileishmanialagents AT lagedanielap 13bisaryloxypropan2olsaspotentialantileishmanialagents AT tavarescarlosap 13bisaryloxypropan2olsaspotentialantileishmanialagents AT coelhoeduardoaf 13bisaryloxypropan2olsaspotentialantileishmanialagents AT alvesricardoj 13bisaryloxypropan2olsaspotentialantileishmanialagents |